Literature DB >> 29733730

Delivery Of Cascade Screening For Hereditary Conditions: A Scoping Review Of The Literature.

Megan C Roberts1, W David Dotson2, Christopher S DeVore3, Erica M Bednar4, Deborah J Bowen5, Theodore G Ganiats6, Ridgely Fisk Green7, Georgia M Hurst8, Alisdair R Philp9, Charité N Ricker10, Amy C Sturm11, Angela M Trepanier12, Janet L Williams13, Heather A Zierhut14, Katherine A Wilemon15, Heather Hampel16.   

Abstract

Cascade screening is the process of contacting relatives of people who have been diagnosed with certain hereditary conditions. Its purpose is to identify, inform, and manage those who are also at risk. We conducted a scoping review to obtain a broad overview of cascade screening interventions, facilitators and barriers to their use, relevant policy considerations, and future research needs. We searched for relevant peer-reviewed literature in the period 1990-2017 and reviewed 122 studies. Finally, we described 45 statutes and regulations related to the use and release of genetic information across the fifty states. We sought standardized best practices for optimizing cascade screening across various geographic and policy contexts, but we found none. Studies in which trained providers contacted relatives directly, rather than through probands (index patients), showed greater cascade screening uptake; however, policies in some states might limit this approach. Major barriers to cascade screening delivery include suboptimal communication between the proband and family and geographic barriers to obtaining genetic services. Few US studies examined interventions for cascade screening or used rigorous study designs such as randomized controlled trials. Moving forward, there remains an urgent need to conduct rigorous intervention studies on cascade screening in diverse US populations, while accounting for state policy considerations.

Entities:  

Keywords:  Cascade screening; Precision medicine; Scoping review

Mesh:

Year:  2018        PMID: 29733730     DOI: 10.1377/hlthaff.2017.1630

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  35 in total

Review 1.  Genetic testing for hereditary gastrointestinal cancer syndromes: Interpreting results in today's practice.

Authors:  Jacquelyn M Powers; Jessica E Ebrahimzadeh; Bryson W Katona
Journal:  Curr Treat Options Gastroenterol       Date:  2019-12

2.  Leveraging Implementation Science to Address Health Disparities in Genomic Medicine: Examples from the Field.

Authors:  Megan C Roberts; George A Mensah; Muin J Khoury
Journal:  Ethn Dis       Date:  2019-02-21       Impact factor: 1.847

3.  Psychosocial, attitudinal, and demographic correlates of cancer-related germline genetic testing in the 2017 Health Information National Trends Survey.

Authors:  Megan C Roberts; Erin Turbitt; William M P Klein
Journal:  J Community Genet       Date:  2019-02-20

4.  Genetic testing in families with hereditary colorectal cancer in British Columbia and Yukon: a retrospective cross-sectional analysis.

Authors:  Vivienne K Beard; Angela C Bedard; Jennifer Nuk; Petra W C Lee; Quan Hong; James E J Bedard; Sophie Sun; Kasmintan A Schrader
Journal:  CMAJ Open       Date:  2020-10-19

Review 5.  Opportunities, resources, and techniques for implementing genomics in clinical care.

Authors:  Teri A Manolio; Robb Rowley; Marc S Williams; Dan Roden; Geoffrey S Ginsburg; Carol Bult; Rex L Chisholm; Patricia A Deverka; Howard L McLeod; George A Mensah; Mary V Relling; Laura Lyman Rodriguez; Cecelia Tamburro; Eric D Green
Journal:  Lancet       Date:  2019-08-05       Impact factor: 79.321

Review 6.  Building evidence and measuring clinical outcomes for genomic medicine.

Authors:  Josh F Peterson; Dan M Roden; Lori A Orlando; Andrea H Ramirez; George A Mensah; Marc S Williams
Journal:  Lancet       Date:  2019-08-05       Impact factor: 79.321

7.  Poor Knowledge of Personal and Familial Colorectal Cancer Risk and Screening Recommendations Associated with Advanced Colorectal Polyps.

Authors:  Swati G Patel; Dennis J Ahnen; Amitha Gumidyala; Jeannine Espinoza; Andrew Nicklawsky; Junxiao Hu; Derek Smith; Jan Lowery; Gregory Austin; Myles Cockburn
Journal:  Dig Dis Sci       Date:  2020-03-06       Impact factor: 3.199

Review 8.  Initiatives to Scale Up and Expand Reach of Cancer Genomic Services Outside of Specialty Clinical Settings: A Systematic Review.

Authors:  Yue Guan; Colleen M McBride; Hannah Rogers; Jingsong Zhao; Caitlin G Allen; Cam Escoffery
Journal:  Am J Prev Med       Date:  2020-11-07       Impact factor: 5.043

9.  Uptake of cancer risk management strategies among women who undergo cascade genetic testing for breast cancer susceptibility genes.

Authors:  Sukh Makhnoon; Grace Tran; Brooke Levin; Kristin D Mattie; Brian Dreyer; Robert J Volk; Generosa Grana; Banu K Arun; Susan K Peterson
Journal:  Cancer       Date:  2021-06-22       Impact factor: 6.860

10.  Barriers to family history knowledge and family communication among LGBTQ+ individuals in the context of hereditary cancer risk assessment.

Authors:  Bradley A Rolf; Jennifer L Schneider; Laura M Amendola; James V Davis; Kathleen F Mittendorf; Mark A Schmidt; Gail P Jarvik; Benjamin S Wilfond; Katrina A B Goddard; Jessica Ezzell Hunter
Journal:  J Genet Couns       Date:  2021-07-23       Impact factor: 2.537

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.